Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | SLGL | EVOK | ||
| Company | Kalobios Pharmaceuticals Inc | Sol-Gel Technologies Ltd | Evoke Pharma | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 1.6500 | 0.4060 | 4.95 | ||
| High | 2.2000 | 1.6500 | 5.03 | ||
| Low | 1.6200 | 0.4050 | 4.80 | ||
| Last | 2.1900 | 1.6500 | 4.96 | ||
| Change | +0.4630 | +1.2210 | -0.11 | ||
| % Change | +26.81% | +284.62% | -2.17% | ||
| Volume | 29,900 | 18,376,100 | 15,500 | ||
| 20-Day Average Volume | 12,700 | 959,245 | 38,810 | ||
| Previous Close | 1.7270 | 0.4290 | 5.07 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 0.5662 | 4.47 | ||
| 20-Day Raw Stochastic | 98.57% | 100.00% | 54.34% | ||
| 20-Day Relative Strength | 60.40% | 85.45% | 52.69% | ||
| Weighted Alpha | -53.96 | -51.38 | -52.20 | ||
| Today's Opinion | N/A | 16% Sell | 40% Sell | ||
| Previous Opinion | N/A | 100% Sell | 32% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +254.15% since 12/16/24 | +8.10% since 12/16/24 | ||
| Low | 1.5700 on 08/02/17 | 0.4050 on 12/23/24 | 4.33 on 12/18/24 | ||
| High | 2.2000 on 08/04/17 | 1.6500 on 12/23/24 | 5.75 on 12/19/24 | ||
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | +208.99% since 11/22/24 | +14.55% since 11/22/24 | ||
| Low | 1.5000 on 07/11/17 | 0.4050 on 12/23/24 | 4.02 on 12/12/24 | ||
| High | 2.2000 on 08/04/17 | 1.6500 on 12/23/24 | 5.75 on 12/19/24 | ||
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | +120.23% since 09/23/24 | -5.70% since 09/23/24 | ||
| Low | 1.5000 on 07/11/17 | 0.4006 on 11/19/24 | 4.02 on 12/12/24 | ||
| High | 2.9500 on 05/17/17 | 1.6500 on 12/23/24 | 12.32 on 10/28/24 | ||
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +98.80% since 06/21/24 | -32.24% since 06/21/24 | ||
| Low | 1.5000 on 07/11/17 | 0.3340 on 08/05/24 | 3.54 on 09/05/24 | ||
| High | 3.2500 on 02/17/17 | 1.6500 on 12/23/24 | 12.32 on 10/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 45,966 | 7,371 | ||
| Shares Outstanding, K | 14,980 | 27,858 | 1,486 | ||
| Annual Sales | 0 | 1,550,000 | 5,180,000 | ||
| Annual Net Income | -27,010,000 | -27,240,000 | -7,790,000 | ||
| Last Quarter Sales | N/A | 5,360,000 | 2,650,000 | ||
| Last Quarter Net Income | N/A | -370,000 | -1,310,000 | ||
| 60-Month Beta | 2.99 | 1.62 | 0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.01 on 11/15/24 | -0.94 on 11/07/24 | ||
| Latest Earnings Date | 09/22/17 | 11/14/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||